275 related articles for article (PubMed ID: 23485065)
21. Allosteric coupling from G protein to the agonist-binding pocket in GPCRs.
DeVree BT; Mahoney JP; Vélez-Ruiz GA; Rasmussen SG; Kuszak AJ; Edwald E; Fung JJ; Manglik A; Masureel M; Du Y; Matt RA; Pardon E; Steyaert J; Kobilka BK; Sunahara RK
Nature; 2016 Jul; 535(7610):182-6. PubMed ID: 27362234
[TBL] [Abstract][Full Text] [Related]
22. Detection of G protein-selective G protein-coupled receptor (GPCR) conformations in live cells.
Malik RU; Ritt M; DeVree BT; Neubig RR; Sunahara RK; Sivaramakrishnan S
J Biol Chem; 2013 Jun; 288(24):17167-78. PubMed ID: 23629648
[TBL] [Abstract][Full Text] [Related]
23. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.
Rasmussen SG; Choi HJ; Fung JJ; Pardon E; Casarosa P; Chae PS; Devree BT; Rosenbaum DM; Thian FS; Kobilka TS; Schnapp A; Konetzki I; Sunahara RK; Gellman SH; Pautsch A; Steyaert J; Weis WI; Kobilka BK
Nature; 2011 Jan; 469(7329):175-80. PubMed ID: 21228869
[TBL] [Abstract][Full Text] [Related]
24. Search for β2 adrenergic receptor ligands by virtual screening via grid computing and investigation of binding modes by docking and molecular dynamics simulations.
Bai Q; Shao Y; Pan D; Zhang Y; Liu H; Yao X
PLoS One; 2014; 9(9):e107837. PubMed ID: 25229694
[TBL] [Abstract][Full Text] [Related]
25. Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators.
Reynolds KA; Katritch V; Abagyan R
J Comput Aided Mol Des; 2009 May; 23(5):273-88. PubMed ID: 19148767
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of intracellular allosteric β
Liu X; Ahn S; Kahsai AW; Meng KC; Latorraca NR; Pani B; Venkatakrishnan AJ; Masoudi A; Weis WI; Dror RO; Chen X; Lefkowitz RJ; Kobilka BK
Nature; 2017 Aug; 548(7668):480-484. PubMed ID: 28813418
[TBL] [Abstract][Full Text] [Related]
27. The structure of active opsin as a basis for identification of GPCR agonists by dynamic homology modelling and virtual screening assays.
Schneider M; Wolf S; Schlitter J; Gerwert K
FEBS Lett; 2011 Nov; 585(22):3587-92. PubMed ID: 22027616
[TBL] [Abstract][Full Text] [Related]
28. An allosteric modulator binds to a conformational hub in the β
Liu X; Kaindl J; Korczynska M; Stößel A; Dengler D; Stanek M; Hübner H; Clark MJ; Mahoney J; Matt RA; Xu X; Hirata K; Shoichet BK; Sunahara RK; Kobilka BK; Gmeiner P
Nat Chem Biol; 2020 Jul; 16(7):749-755. PubMed ID: 32483378
[TBL] [Abstract][Full Text] [Related]
29. Understanding the effects on constitutive activation and drug binding of a D130N mutation in the β2 adrenergic receptor via molecular dynamics simulation.
Zhu Y; Yuan Y; Xiao X; Zhang L; Guo Y; Pu X
J Mol Model; 2014 Nov; 20(11):2491. PubMed ID: 25342155
[TBL] [Abstract][Full Text] [Related]
30. Allosteric "beta-blocker" isolated from a DNA-encoded small molecule library.
Ahn S; Kahsai AW; Pani B; Wang QT; Zhao S; Wall AL; Strachan RT; Staus DP; Wingler LM; Sun LD; Sinnaeve J; Choi M; Cho T; Xu TT; Hansen GM; Burnett MB; Lamerdin JE; Bassoni DL; Gavino BJ; Husemoen G; Olsen EK; Franch T; Costanzi S; Chen X; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1708-1713. PubMed ID: 28130548
[TBL] [Abstract][Full Text] [Related]
31. Function-specific virtual screening for GPCR ligands using a combined scoring method.
Kooistra AJ; Vischer HF; McNaught-Flores D; Leurs R; de Esch IJ; de Graaf C
Sci Rep; 2016 Jun; 6():28288. PubMed ID: 27339552
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of pepducins as Gs-biased allosteric agonists.
Carr R; Du Y; Quoyer J; Panettieri RA; Janz JM; Bouvier M; Kobilka BK; Benovic JL
J Biol Chem; 2014 Dec; 289(52):35668-84. PubMed ID: 25395624
[TBL] [Abstract][Full Text] [Related]
33. The Principles of Ligand Specificity on beta-2-adrenergic receptor.
Chan HC; Filipek S; Yuan S
Sci Rep; 2016 Oct; 6():34736. PubMed ID: 27703221
[TBL] [Abstract][Full Text] [Related]
34. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
35. β2-Adrenergic Receptors Chaperone Trapped Bitter Taste Receptor 14 to the Cell Surface as a Heterodimer and Exert Unidirectional Desensitization of Taste Receptor Function.
Kim D; Pauer SH; Yong HM; An SS; Liggett SB
J Biol Chem; 2016 Aug; 291(34):17616-28. PubMed ID: 27342779
[TBL] [Abstract][Full Text] [Related]
36. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
37. Structure-based discovery of beta2-adrenergic receptor ligands.
Kolb P; Rosenbaum DM; Irwin JJ; Fung JJ; Kobilka BK; Shoichet BK
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6843-8. PubMed ID: 19342484
[TBL] [Abstract][Full Text] [Related]
38. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
39. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
[TBL] [Abstract][Full Text] [Related]
40. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
Dalton JA; Lans I; Giraldo J
BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
